Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety and Efficacy of Insulin Aspart vs. Regular Human Insulin in Gestational Diabetes

This study has been completed.
Information provided by:
Novo Nordisk A/S Identifier:
First received: July 17, 2003
Last updated: May 21, 2012
Last verified: May 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2003
  Primary Completion Date: December 2003 (Final data collection date for primary outcome measure)